compare glp-1 drugs McKee's proposed FY2027 budget drops for weight loss from Medicaid • Rhode Island Current GLP-1 Trends: Lifestyle Changes, Dining

Are triglycerides, cholesterol, and blood pressure improving

To overcome the short half-life and frequent subcutaneous administration of pramlintide, new amylin receptor agonists like cagrilintide have been developed

Additionally, new formulary strategies, including generics prioritization, are impacting accessibility

doi:10.1111/j.1478-3231.2010.02264.x 171

In isolated rat islets, GLP-1 acts as a growth factor in a dose-dependent manner to increase the incorporation of tritiated thymidine and promotes cell proliferation through the upregulation of PI3K-mediated pathways (Sjholm, 1996

Data analysed by paired two-tailed Students t-test ( j - m ), unpaired two-tailed Students t-test ( p and r ), one-way ANOVA, multiple comparison, Bonferroni post hoc test ( h ) and two-way repeated measures ANOVA to assess main effects of treatment ( c , d and s - v )